Association between US norepinephrine shortage and mortality among patients with septic shock

JAMA - Journal of the American Medical Association

Volumn 317, Issue 14, 2017, Pages 1433-1442

  Vail, Emily ^a   Gershengorn, Hayley B ^b   Hua, May ^a,c   Walkey, Allan J ^a,d   Rubenfeld, Gordon ^e,f   Wunsch, Hannah ^e,f,g  

^a Columbia University ^*  (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c Department of Medicine   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; EPINEPHRINE; NORADRENALIN; PHENYLEPHRINE; VASOPRESSIN; VASOCONSTRICTOR AGENT;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; DRUG SHORTAGE; DRUG USE; FEMALE; HOSPITAL ADMISSION; HOSPITAL MORTALITY; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SEPTIC SHOCK; TEACHING HOSPITAL; UNITED STATES; CLINICAL TRIAL; FACTUAL DATABASE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; SHOCK, SEPTIC; STATISTICS AND NUMERICAL DATA; SUPPLY AND DISTRIBUTION;

AGED; DATABASES, FACTUAL; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; NOREPINEPHRINE; OUTCOME ASSESSMENT (HEALTH CARE); PHENYLEPHRINE; RETROSPECTIVE STUDIES; SHOCK, SEPTIC; UNITED STATES; VASOCONSTRICTOR AGENTS;

EID: 85017507665     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2017.2841     Document Type: Article

References (28)

1. Gatesman ML, Smith TJ. The shortage of essential chemotherapy drugs in the United States. N Engl J Med. 2011;365(18):1653-1655.
2. Griffith MM, Pentoney Z, Scheetz MH. Antimicrobial drug shortages: A crisis amidst the epidemic and the need for antimicrobial stewardship efforts to lessen the effects. Pharmacotherapy. 2012;32(8):665-667.
3. Fox ER, Sweet BV, Jensen V. Drug shortages: A complex health care crisis. Mayo Clin Proc. 2014; 89(3):361-373.
4. Roberts R, Ruthazer R, Chi A, et al. Impact of a national propofol shortage on duration of mechanical ventilation at an academic medical center. Crit Care Med. 2012;40(2):406-411.
5. Thoma BN, Li J, McDaniel CM, Wordell CJ, Cavarocchi N, Pizzi LT. Clinical and economic impact of substituting dexmedetomidine for propofol due to a US drug shortage: Examination of coronary artery bypass graft patients at an urban medical centre. Pharmacoeconomics. 2014;32(2):149-157.
6. Kaakeh R, Sweet BV, Reilly C, et al. Impact of drug shortages on U.S. health systems. Am J Health Syst Pharm. 2011;68(19):1811-1819.
7. US Food and Drug Administration. Current drug shortages. https://web.archive.org/web/20110202172802/http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm050792.htm 2011. Accessed February 6, 2016.
8. Dellinger RP, Levy MM, Carlet JM, et al; International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society;World Federation of Societies of Intensive and Critical Care Medicine. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36(1): 296-327.
9. Premier Inc. Premier Healthcare Database. https://www.premierinc.com/transforming-healthcare/healthcare-performance-improvement/premier-research-services/Accessed February 12, 2017.
10. Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med. 2005;353(4): 349-361.
11. Rothberg MB, Pekow PS, Lahti M, Brody O, Skiest DJ, Lindenauer PK. Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. JAMA. 2010;303(20):2035-2042.
12. Schneeweiss S, Seeger JD, Landon J, Walker AM. Aprotinin during coronary-Artery bypass grafting and risk of death. N Engl J Med. 2008;358(8):771-783.
13. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303-1310.
14. Iwashyna TJ, Odden A, Rohde J, et al. Identifying patients with severe sepsis using administrative claims: patient-level validation of the Angus implementation of the international consensus conference definition of severe sepsis. Med Care. 2014;52(6):e39-e43.
15. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8-27.
16. Barnato AE, Alexander SL, Linde-Zwirble WT, Angus DC. Racial variation in the incidence, care, and outcomes of severe sepsis: Analysis of population, patient, and hospital characteristics. Am J Respir Crit Care Med. 2008;177(3):279-284.
17. Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project (HCUP) Procedure Classes. Rockville, MD: Agency for Healthcare Research & Quality; 2014.
18. Begg MD, Parides MK. Separation of individual-level and cluster-level covariate effects in regression analysis of correlated data. Stat Med. 2003;22(16):2591-2602.
19. Enders CK, Tofighi D. Centering predictor variables in cross-sectional multilevel models: A new look at an old issue. Psychol Methods. 2007; 12(2):121-138.
20. Dimick JB, Ryan AM. Methods for evaluating changes in health care policy: The difference-in-differences approach. JAMA. 2014;312(22):2401-2402.
21. Centers for Disease Control and Prevention. Interruptions in supplies of second-line antituberculosis drugs-United States, 2005-2012. MMWR Morb Mortal Wkly Rep. 2013;62(2):23-26.
22. Mayr FB, Yende S, Angus DC. Epidemiology of severe sepsis. Virulence. 2014;5(1):4-11.
23. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369(9):840-851.
24. Morelli A, Lange M, Ertmer C, et al. Short-Term effects of phenylephrine on systemic and regional hemodynamics in patients with septic shock: A crossover pilot study. Shock. 2008;29(4):446-451.
25. Morelli A, Ertmer C, Rehberg S, et al. Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: A randomized, controlled trial. Crit Care. 2008;12(6):R143.
26. Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017;45(3):486-552.
27. Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315 (8):801-810.
28. Hall WB, Willis LE, Medvedev S, Carson SS. The implications of long-Term acute care hospital transfer practices for measures of in-hospital mortality and length of stay. Am J Respir Crit Care Med. 2012;185(1):53-57.